Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention
(Abstracted from N Engl J Med 2016;375:1726–1737) Antiretroviral regimens used for the prevention of mother-to-child transmission of the human immunodeficiency virus (HIV) have evolved over the years. Combination antiretroviral therapy (ART) is currently used for prevention of mother-to-child transm...
Gespeichert in:
| Veröffentlicht in: | Obstetrical & gynecological survey 2017-03, Vol.72 (3), p.143-145 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 145 |
|---|---|
| container_issue | 3 |
| container_start_page | 143 |
| container_title | Obstetrical & gynecological survey |
| container_volume | 72 |
| creator | Fowler, Mary G. Qin, Min Fiscus, Susan A. Currier, Judith S. Flynn, Patricia M. Chipato, Tsungai McIntyre, James Gnanashanmugam, Devasena Siberry, George K. Coletti, Anne S. Taha, Taha E. Klingman, Karin L. Martinson, Francis E. Owor, Maxensia Violari, Avy Moodley, Dhayendre Theron, Gerhard B. Bhosale, Ramesh Bobat, Raziya Chi, Benjamin H. Strehlau, Renate Mlay, Pendo Loftis, Amy J. Browning, Renee Fenton, Terence Purdue, Lynette Basar, Michael Shapiro, David E. Mofenson, Lynne M. |
| description | (Abstracted from
N Engl J Med
2016;375:1726–1737)
Antiretroviral regimens used for the prevention of mother-to-child transmission of the human immunodeficiency virus (HIV) have evolved over the years. Combination antiretroviral therapy (ART) is currently used for prevention of mother-to-child transmission of HIV but has shown more adverse effects compared with regimens containing fewer antiretroviral agents. |
| doi_str_mv | 10.1097/OGX.0000000000000427 |
| format | Article |
| fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1097_OGX_0000000000000427</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1097_OGX_0000000000000427</sourcerecordid><originalsourceid>FETCH-LOGICAL-c246t-c66c8a1f3a8d980d6c78cbcac43f84021d53186a0a0e30c5520e8c7d40517eca3</originalsourceid><addsrcrecordid>eNpdkFFLwzAUhYMoWKf_wIf8gc6bJk3Sxzl0Kww2ZIpv5ZreYHS2IymD_Xs79EE8LwcOH-fhY-xWwFRAZe7Wi9cp_I0qzBnLRCllXlmtz1kGUFS5sYW9ZFcpfYyMlQoyVt9TRz4MiWPX8qeQPhPvPZ91Q4g0xP4QIu749p0i7o_c95FvKIYOh3Fd1i98E-lAI9x31-zC4y7RzW9P2PPjw3a-zFfrRT2frXJXKD3kTmtnUXiJtq0stNoZ694cOiW9VVCItpTCagQEkuDKsgCyzrQKSmHIoZww9fPrYp9SJN_sY_jCeGwENCcdzaij-a9DfgNZg1L9</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention</title><source>Journals@Ovid Complete</source><creator>Fowler, Mary G. ; Qin, Min ; Fiscus, Susan A. ; Currier, Judith S. ; Flynn, Patricia M. ; Chipato, Tsungai ; McIntyre, James ; Gnanashanmugam, Devasena ; Siberry, George K. ; Coletti, Anne S. ; Taha, Taha E. ; Klingman, Karin L. ; Martinson, Francis E. ; Owor, Maxensia ; Violari, Avy ; Moodley, Dhayendre ; Theron, Gerhard B. ; Bhosale, Ramesh ; Bobat, Raziya ; Chi, Benjamin H. ; Strehlau, Renate ; Mlay, Pendo ; Loftis, Amy J. ; Browning, Renee ; Fenton, Terence ; Purdue, Lynette ; Basar, Michael ; Shapiro, David E. ; Mofenson, Lynne M.</creator><creatorcontrib>Fowler, Mary G. ; Qin, Min ; Fiscus, Susan A. ; Currier, Judith S. ; Flynn, Patricia M. ; Chipato, Tsungai ; McIntyre, James ; Gnanashanmugam, Devasena ; Siberry, George K. ; Coletti, Anne S. ; Taha, Taha E. ; Klingman, Karin L. ; Martinson, Francis E. ; Owor, Maxensia ; Violari, Avy ; Moodley, Dhayendre ; Theron, Gerhard B. ; Bhosale, Ramesh ; Bobat, Raziya ; Chi, Benjamin H. ; Strehlau, Renate ; Mlay, Pendo ; Loftis, Amy J. ; Browning, Renee ; Fenton, Terence ; Purdue, Lynette ; Basar, Michael ; Shapiro, David E. ; Mofenson, Lynne M.</creatorcontrib><description>(Abstracted from
N Engl J Med
2016;375:1726–1737)
Antiretroviral regimens used for the prevention of mother-to-child transmission of the human immunodeficiency virus (HIV) have evolved over the years. Combination antiretroviral therapy (ART) is currently used for prevention of mother-to-child transmission of HIV but has shown more adverse effects compared with regimens containing fewer antiretroviral agents.</description><identifier>ISSN: 0029-7828</identifier><identifier>EISSN: 1533-9866</identifier><identifier>DOI: 10.1097/OGX.0000000000000427</identifier><language>eng</language><ispartof>Obstetrical & gynecological survey, 2017-03, Vol.72 (3), p.143-145</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Fowler, Mary G.</creatorcontrib><creatorcontrib>Qin, Min</creatorcontrib><creatorcontrib>Fiscus, Susan A.</creatorcontrib><creatorcontrib>Currier, Judith S.</creatorcontrib><creatorcontrib>Flynn, Patricia M.</creatorcontrib><creatorcontrib>Chipato, Tsungai</creatorcontrib><creatorcontrib>McIntyre, James</creatorcontrib><creatorcontrib>Gnanashanmugam, Devasena</creatorcontrib><creatorcontrib>Siberry, George K.</creatorcontrib><creatorcontrib>Coletti, Anne S.</creatorcontrib><creatorcontrib>Taha, Taha E.</creatorcontrib><creatorcontrib>Klingman, Karin L.</creatorcontrib><creatorcontrib>Martinson, Francis E.</creatorcontrib><creatorcontrib>Owor, Maxensia</creatorcontrib><creatorcontrib>Violari, Avy</creatorcontrib><creatorcontrib>Moodley, Dhayendre</creatorcontrib><creatorcontrib>Theron, Gerhard B.</creatorcontrib><creatorcontrib>Bhosale, Ramesh</creatorcontrib><creatorcontrib>Bobat, Raziya</creatorcontrib><creatorcontrib>Chi, Benjamin H.</creatorcontrib><creatorcontrib>Strehlau, Renate</creatorcontrib><creatorcontrib>Mlay, Pendo</creatorcontrib><creatorcontrib>Loftis, Amy J.</creatorcontrib><creatorcontrib>Browning, Renee</creatorcontrib><creatorcontrib>Fenton, Terence</creatorcontrib><creatorcontrib>Purdue, Lynette</creatorcontrib><creatorcontrib>Basar, Michael</creatorcontrib><creatorcontrib>Shapiro, David E.</creatorcontrib><creatorcontrib>Mofenson, Lynne M.</creatorcontrib><title>Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention</title><title>Obstetrical & gynecological survey</title><description>(Abstracted from
N Engl J Med
2016;375:1726–1737)
Antiretroviral regimens used for the prevention of mother-to-child transmission of the human immunodeficiency virus (HIV) have evolved over the years. Combination antiretroviral therapy (ART) is currently used for prevention of mother-to-child transmission of HIV but has shown more adverse effects compared with regimens containing fewer antiretroviral agents.</description><issn>0029-7828</issn><issn>1533-9866</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNpdkFFLwzAUhYMoWKf_wIf8gc6bJk3Sxzl0Kww2ZIpv5ZreYHS2IymD_Xs79EE8LwcOH-fhY-xWwFRAZe7Wi9cp_I0qzBnLRCllXlmtz1kGUFS5sYW9ZFcpfYyMlQoyVt9TRz4MiWPX8qeQPhPvPZ91Q4g0xP4QIu749p0i7o_c95FvKIYOh3Fd1i98E-lAI9x31-zC4y7RzW9P2PPjw3a-zFfrRT2frXJXKD3kTmtnUXiJtq0stNoZ694cOiW9VVCItpTCagQEkuDKsgCyzrQKSmHIoZww9fPrYp9SJN_sY_jCeGwENCcdzaij-a9DfgNZg1L9</recordid><startdate>201703</startdate><enddate>201703</enddate><creator>Fowler, Mary G.</creator><creator>Qin, Min</creator><creator>Fiscus, Susan A.</creator><creator>Currier, Judith S.</creator><creator>Flynn, Patricia M.</creator><creator>Chipato, Tsungai</creator><creator>McIntyre, James</creator><creator>Gnanashanmugam, Devasena</creator><creator>Siberry, George K.</creator><creator>Coletti, Anne S.</creator><creator>Taha, Taha E.</creator><creator>Klingman, Karin L.</creator><creator>Martinson, Francis E.</creator><creator>Owor, Maxensia</creator><creator>Violari, Avy</creator><creator>Moodley, Dhayendre</creator><creator>Theron, Gerhard B.</creator><creator>Bhosale, Ramesh</creator><creator>Bobat, Raziya</creator><creator>Chi, Benjamin H.</creator><creator>Strehlau, Renate</creator><creator>Mlay, Pendo</creator><creator>Loftis, Amy J.</creator><creator>Browning, Renee</creator><creator>Fenton, Terence</creator><creator>Purdue, Lynette</creator><creator>Basar, Michael</creator><creator>Shapiro, David E.</creator><creator>Mofenson, Lynne M.</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201703</creationdate><title>Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention</title><author>Fowler, Mary G. ; Qin, Min ; Fiscus, Susan A. ; Currier, Judith S. ; Flynn, Patricia M. ; Chipato, Tsungai ; McIntyre, James ; Gnanashanmugam, Devasena ; Siberry, George K. ; Coletti, Anne S. ; Taha, Taha E. ; Klingman, Karin L. ; Martinson, Francis E. ; Owor, Maxensia ; Violari, Avy ; Moodley, Dhayendre ; Theron, Gerhard B. ; Bhosale, Ramesh ; Bobat, Raziya ; Chi, Benjamin H. ; Strehlau, Renate ; Mlay, Pendo ; Loftis, Amy J. ; Browning, Renee ; Fenton, Terence ; Purdue, Lynette ; Basar, Michael ; Shapiro, David E. ; Mofenson, Lynne M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c246t-c66c8a1f3a8d980d6c78cbcac43f84021d53186a0a0e30c5520e8c7d40517eca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fowler, Mary G.</creatorcontrib><creatorcontrib>Qin, Min</creatorcontrib><creatorcontrib>Fiscus, Susan A.</creatorcontrib><creatorcontrib>Currier, Judith S.</creatorcontrib><creatorcontrib>Flynn, Patricia M.</creatorcontrib><creatorcontrib>Chipato, Tsungai</creatorcontrib><creatorcontrib>McIntyre, James</creatorcontrib><creatorcontrib>Gnanashanmugam, Devasena</creatorcontrib><creatorcontrib>Siberry, George K.</creatorcontrib><creatorcontrib>Coletti, Anne S.</creatorcontrib><creatorcontrib>Taha, Taha E.</creatorcontrib><creatorcontrib>Klingman, Karin L.</creatorcontrib><creatorcontrib>Martinson, Francis E.</creatorcontrib><creatorcontrib>Owor, Maxensia</creatorcontrib><creatorcontrib>Violari, Avy</creatorcontrib><creatorcontrib>Moodley, Dhayendre</creatorcontrib><creatorcontrib>Theron, Gerhard B.</creatorcontrib><creatorcontrib>Bhosale, Ramesh</creatorcontrib><creatorcontrib>Bobat, Raziya</creatorcontrib><creatorcontrib>Chi, Benjamin H.</creatorcontrib><creatorcontrib>Strehlau, Renate</creatorcontrib><creatorcontrib>Mlay, Pendo</creatorcontrib><creatorcontrib>Loftis, Amy J.</creatorcontrib><creatorcontrib>Browning, Renee</creatorcontrib><creatorcontrib>Fenton, Terence</creatorcontrib><creatorcontrib>Purdue, Lynette</creatorcontrib><creatorcontrib>Basar, Michael</creatorcontrib><creatorcontrib>Shapiro, David E.</creatorcontrib><creatorcontrib>Mofenson, Lynne M.</creatorcontrib><collection>CrossRef</collection><jtitle>Obstetrical & gynecological survey</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fowler, Mary G.</au><au>Qin, Min</au><au>Fiscus, Susan A.</au><au>Currier, Judith S.</au><au>Flynn, Patricia M.</au><au>Chipato, Tsungai</au><au>McIntyre, James</au><au>Gnanashanmugam, Devasena</au><au>Siberry, George K.</au><au>Coletti, Anne S.</au><au>Taha, Taha E.</au><au>Klingman, Karin L.</au><au>Martinson, Francis E.</au><au>Owor, Maxensia</au><au>Violari, Avy</au><au>Moodley, Dhayendre</au><au>Theron, Gerhard B.</au><au>Bhosale, Ramesh</au><au>Bobat, Raziya</au><au>Chi, Benjamin H.</au><au>Strehlau, Renate</au><au>Mlay, Pendo</au><au>Loftis, Amy J.</au><au>Browning, Renee</au><au>Fenton, Terence</au><au>Purdue, Lynette</au><au>Basar, Michael</au><au>Shapiro, David E.</au><au>Mofenson, Lynne M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention</atitle><jtitle>Obstetrical & gynecological survey</jtitle><date>2017-03</date><risdate>2017</risdate><volume>72</volume><issue>3</issue><spage>143</spage><epage>145</epage><pages>143-145</pages><issn>0029-7828</issn><eissn>1533-9866</eissn><abstract>(Abstracted from
N Engl J Med
2016;375:1726–1737)
Antiretroviral regimens used for the prevention of mother-to-child transmission of the human immunodeficiency virus (HIV) have evolved over the years. Combination antiretroviral therapy (ART) is currently used for prevention of mother-to-child transmission of HIV but has shown more adverse effects compared with regimens containing fewer antiretroviral agents.</abstract><doi>10.1097/OGX.0000000000000427</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0029-7828 |
| ispartof | Obstetrical & gynecological survey, 2017-03, Vol.72 (3), p.143-145 |
| issn | 0029-7828 1533-9866 |
| language | eng |
| recordid | cdi_crossref_primary_10_1097_OGX_0000000000000427 |
| source | Journals@Ovid Complete |
| title | Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T15%3A59%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Benefits%20and%20Risks%20of%20Antiretroviral%20Therapy%20for%20Perinatal%20HIV%20Prevention&rft.jtitle=Obstetrical%20&%20gynecological%20survey&rft.au=Fowler,%20Mary%20G.&rft.date=2017-03&rft.volume=72&rft.issue=3&rft.spage=143&rft.epage=145&rft.pages=143-145&rft.issn=0029-7828&rft.eissn=1533-9866&rft_id=info:doi/10.1097/OGX.0000000000000427&rft_dat=%3Ccrossref%3E10_1097_OGX_0000000000000427%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |